HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sunshine, G. H. Articles by Hadden, J. W. Search for Related Content PubMed Articles by Sunshine, G. H. Articles by Hadden, J. W.

Thymopoietin Enhances the Allogeneic Response and Cyclic GMP Levels of Mouse Peripheral, Thymus-Derived Lymphocytes¹

From the Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York and the Department of Pathology, New York University Medical Center, 550 First Avenue, New York

Abstract

The action of the purified thymic factor, thymopoietin, on populations of post-thymic lymphocytes has been studied. Thymopoietin, at concentrations as low as 1.5 ng/ml, uniquely enhanced the proliferative response of peripheral T cells from lymph node and spleen to allogeneic stimulation. Enhancement of the allogeneic response (MLR) was not produced by several polypeptide hormones, including insulin, ACTH, HCG, or Ubiquitin. Treatment of spleen cells with anti-Thy-1 antiserum almost completely abolished the MLR. Thymopoietin's stimulatory effects could not reverse this. Thymopoietin treatment of Thy-1⁺-enriched spleen cell populations enhanced the MLR even when thymopoietin was removed as early as 2 min after incubation with responding cells. The interaction of thymopoietin with peripheral Thy-1⁺ cell populations produced a rapid and transient rise in cyclic GMP levels and slightly decreased cyclic AMP levels. These results suggest that thymopoietin interacts with one or more Thy-1⁺ subpopulations and that this interaction involves early changes in cyclic nucleotide metabolism.

Footnotes

¹ This work was supported by grants from the National Institutes of Health and the American Heart Association (AHA).

² JWH is an Established Investigator of the AHA.

This article has been cited by other articles:

				T Audhya, D Kroon, G Heavner, G Viamontes, and G Goldstein Tripeptide structure of bursin, a selective B-cell-differentiating hormone of the bursa of fabricius Science, February 28, 1986; 231(4741): 997 - 999. [Abstract] [PDF]

				G Goldstein, M. Scheid, E. Boyse, D. Schlesinger, and J Van Wauwe A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin Science, June 22, 1979; 204(4399): 1309 - 1310. [Abstract] [PDF]